TL;DR: FidoCure® is a Y Combinator Winter 2018 startup the leader in Precision Medicine for Canine Oncology., currently active with a team of 14.
FidoCure® is the leader in Precision Medicine for Canine Oncology.
Last verified:
Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!
Built by LemStudio
Yes. FidoCure® was funded by Y Combinator in the Winter 2018 batch. FidoCure® is the leader in Precision Medicine for Canine Oncology.
Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequen…
FidoCure® was part of Y Combinator's Winter 2018 batch.
FidoCure® has a team of 14 people according to Y Combinator's directory.
FidoCure® is currently listed as Active with a team of 14 in Y Combinator's directory.
Loading interactive view…